Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Shinjiro Kaieda"'
Autor:
Masaki Okamoto, Yoshiaki Zaizen, Shinjiro Kaieda, Takashi Nouno, Takuma Koga, Goushi Matama, Masahiro Mitsuoka, Jun Akiba, Shintaro Yamada, Hiroki Kato, Tomoaki Hoshino
Publikováno v:
Heliyon, Vol 10, Iss 11, Pp e31727- (2024)
Viral double-stranded RNA (dsRNA) is sensed by toll-like receptor 3 (TLR3) and retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs), including melanoma differentiation-associated gene 5 (MDA5). MDA5 recognizes the genome of dsRNA viruses and
Externí odkaz:
https://doaj.org/article/8b8478b759654b2a8704924d6b1052e2
Autor:
Takuma Koga, Masaki Okamoto, Minoru Satoh, Kiminori Fujimoto, Yoshiaki Zaizen, Tomonori Chikasue, Akiko Sumi, Shinjiro Kaieda, Norikazu Matsuo, Goushi Matama, Takashi Nouno, Masaki Tominaga, Kazuhiro Yatera, Hiroaki Ida, Tomoaki Hoshino
Publikováno v:
Biomedicines, Vol 10, Iss 10, p 2469 (2022)
Various autoantibodies are associated with clinical outcomes in patients with idiopathic interstitial pneumonias (IIPs). We retrospectively analyzed the association between autoantibodies and malignancies in IIP patients. Comprehensive analyses of au
Externí odkaz:
https://doaj.org/article/906cfb768a5f4414a7399ac800f68052
Autor:
Shinjiro Kaieda, Takahisa Gono, Kenichi Masui, Naoshi Nishina, Shinji Sato, Masataka Kuwana, A Multicenter Retrospective Cohort of Japanese Patients with Myositis-associated ILD (JAMI) investigators
Publikováno v:
PLoS ONE, Vol 15, Iss 6, p e0234523 (2020)
ObjectiveSurfactant protein D (SP-D) is considered a serum biomarker of various forms of interstitial lung disease (ILD). In this study, we examined the utility of SP-D as a predictive biomarker for mortality in patients with ILD associated with poly
Externí odkaz:
https://doaj.org/article/74af3ac9d88044009e712a573db7632a
Autor:
Yukio Fujiwara, Koji Ohnishi, Hasita Horlad, Yoichi Saito, Daisuke Shiraishi, Hiroto Takeya, Daiki Yoshii, Shinjiro Kaieda, Tomoaki Hoshino, Yoshihiro Komohara
Publikováno v:
Clinical & Translational Immunology, Vol 9, Iss 9, Pp n/a-n/a (2020)
Abstract Objectives Septic (or endotoxin) shock is a severe systemic inflammatory disease caused by bacteraemia or endotoxaemia. Although it is known that increased serum levels of CD163 are observed in septic/endotoxin shock patients, the exact func
Externí odkaz:
https://doaj.org/article/a50d7bbd6d5245e0a3beb21df1fba037
Autor:
Shinjiro Kaieda, Jun-Xia Wang, Ruslan Shnayder, Nadia Fishgal, Hillary Hei, Richard T Lee, Richard L Stevens, Peter A Nigrovic
Publikováno v:
PLoS ONE, Vol 7, Iss 10, p e47252 (2012)
Mast cells (MCs) are heterogeneous cells whose phenotype is modulated by signals received from the local microenvironment. Recent studies have identified the mesenchymal-derived cytokine IL-33 as a potent direct activator of MCs, as well as regulator
Externí odkaz:
https://doaj.org/article/6c3e5aa31d754a80889cd7613f7c7622
Autor:
Masahiro Tsutsumi, T. Koga, Aya Kawaguchi, Hiroaki Ida, Yumi Harada, Makiko Hayashi, Shinjiro Kaieda, Jun Akiba, Tomoaki Hoshino
Publikováno v:
Internal Medicine
We herein report an unusual case of granulomatosis with polyangiitis (GPA) in a 65-year-old man in whom relapsed disease manifested as an anterior cheek nodule. Magnetic resonance imaging indicated the differential diagnoses of the subcutaneous nodul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cf520b0a8368b05e8f987e77136277a
http://europepmc.org/articles/PMC8710381
http://europepmc.org/articles/PMC8710381
Autor:
Ryuta Nishikomori, Ken Yamamoto, Satoshi Yamasaki, Shinjiro Kaieda, Munetoshi Nakashima, Kyoko Fujimoto, Yukiko Hidaka, T. Koga, Hiroaki Ida, Tomoaki Hoshino
Publikováno v:
Modern Rheumatology. 31:1208-1214
Objective To investigate the genetic characteristics of one of the MEFV gene variants, p.Glu148Gln (E148Q), in patients with familial Mediterranean fever (FMF) and examine its significance in Japanese patients with recurrent fever. Methods The clinic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7ba16a67040815bfed4ee82f78af1aa
https://doi.org/10.1080/14397595.2021.1880534
https://doi.org/10.1080/14397595.2021.1880534
Autor:
Hiroaki Ida, Shinjiro Kaieda, Jingo Kusukawa, Yushi Abe, Tomoaki Hoshino, Kyoko Fujimoto, Keita Todoroki
Publikováno v:
Modern Rheumatology. 32:761-769
Objectives This study investigated the associations of mast cells with immune-mediated inflammation and fibrosis in patients with primary Sjögren’s syndrome (pSS); it also explored the underlying pathophysiology of pSS-related sialadenitis. Method
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e17558b3c44171fd609351f27208c329
https://doi.org/10.1093/mr/roab051
https://doi.org/10.1093/mr/roab051
Autor:
Takahisa, Gono, Kenichi, Masui, Naoshi, Nishina, Yasushi, Kawaguchi, Atsushi, Kawakami, Kei, Ikeda, Yohei, Kirino, Yumiko, Sugiyama, Yoshinori, Tanino, Takahiro, Nunokawa, Yuko, Kaneko, Shinji, Sato, Katsuaki, Asakawa, Taro, Ukichi, Shinjiro, Kaieda, Taio, Naniwa, Yutaka, Okano, Masataka, Kuwana, Yoshie, Kawahara
Publikováno v:
Arthritis & Rheumatology. 73:677-686
OBJECTIVE To establish predictive models for mortality in patients with polymyositis/dermatomyositis-associated interstitial lung disease (PM/DM-ILD) using a combination of initial serum biomarker levels. METHODS The Multicenter Retrospective Cohort
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f09b23b8fc5ce22f30f8076c1ff91383
https://doi.org/10.1002/art.41566
https://doi.org/10.1002/art.41566
Clinical Characteristics of Anti-TIF-1γ Antibody-Positive Dermatomyositis Associated with Malignancy
Autor:
Yumi Harada, Masaki Tominaga, Eriko Iitoh, Shinjiro Kaieda, Takuma Koga, Kiminori Fujimoto, Tomonori Chikasue, Hitoshi Obara, Tatsuyuki Kakuma, Hiroaki Ida, Tomotaka Kawayama, Tomoaki Hoshino
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 7; Pages: 1925
We retrospectively analyzed the clinical and laboratory data of patients diagnosed with anti-transcriptional intermediary factor 1 (TIF-1γ) antibody-positive polymyositis (PM)/dermatomyositis (DM) to clarify the characteristics of this disease. We i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2019af9a04d1e29c02f782b8b81de4ba